Improving generalizability and study design of Alzheimer’s disease cohort studies in the United States by including under-represented populations
dc.contributor.author | Mindt, Monica Rivera | |
dc.contributor.author | Okonkwo, Ozioma | |
dc.contributor.author | Weiner, Michael W. | |
dc.contributor.author | Veitch, Dallas P. | |
dc.contributor.author | Aisen, Paul | |
dc.contributor.author | Ashford, Miriam | |
dc.contributor.author | Coker, Godfrey | |
dc.contributor.author | Donohue, Michael C. | |
dc.contributor.author | Langa, Kenneth M. | |
dc.contributor.author | Miller, Garrett | |
dc.contributor.author | Petersen, Ronald | |
dc.contributor.author | Raman, Rema | |
dc.contributor.author | Nosheny, Rachel | |
dc.date.accessioned | 2023-05-01T19:12:27Z | |
dc.date.available | 2024-05-01 15:12:25 | en |
dc.date.available | 2023-05-01T19:12:27Z | |
dc.date.issued | 2023-04 | |
dc.identifier.citation | Mindt, Monica Rivera; Okonkwo, Ozioma; Weiner, Michael W.; Veitch, Dallas P.; Aisen, Paul; Ashford, Miriam; Coker, Godfrey; Donohue, Michael C.; Langa, Kenneth M.; Miller, Garrett; Petersen, Ronald; Raman, Rema; Nosheny, Rachel (2023). "Improving generalizability and study design of Alzheimer’s disease cohort studies in the United States by including under-represented populations." Alzheimer’s & Dementia 19(4): 1549-1557. | |
dc.identifier.issn | 1552-5260 | |
dc.identifier.issn | 1552-5279 | |
dc.identifier.uri | https://hdl.handle.net/2027.42/176313 | |
dc.description.abstract | The poor generalizability of clinical research data due to the enrollment of highly educated, non-Latinx White participants hampers the development of therapies for Alzheimer’s disease (AD). Black and Latinx older adults have a greater risk for dementia, yet it is unclear how health-care disparities and sociocultural factors influence potential AD therapies and prognosis. Low enrollment of under-represented populations may be attributable to several factors including greater exclusion due to higher rates of comorbidities, lower access to AD clinics, and the legacy of unethical treatment in medical research. This perspective outlines solutions tested in the Brain Health Registry (BHR) and the Alzheimer’s Disease Neuroimaging Initiative (ADNI), including culturally-informed digital research methods, community-engaged research strategies, leadership from under-represented communities, and the reduction of exclusion criteria based on comorbidities. Our successes demonstrate that it is possible to increase the inclusion and engagement of under-represented populations into US-based clinical studies, thereby increasing the generalizability of their results. | |
dc.publisher | Wiley Periodicals, Inc. | |
dc.publisher | OECD Publishing Paris | |
dc.title | Improving generalizability and study design of Alzheimer’s disease cohort studies in the United States by including under-represented populations | |
dc.type | Article | |
dc.rights.robots | IndexNoFollow | |
dc.subject.hlbsecondlevel | Neurology and Neurosciences | |
dc.subject.hlbtoplevel | Health Sciences | |
dc.description.peerreviewed | Peer Reviewed | |
dc.description.bitstreamurl | http://deepblue.lib.umich.edu/bitstream/2027.42/176313/1/alz12823-sup-0001-ICMJE.pdf | |
dc.description.bitstreamurl | http://deepblue.lib.umich.edu/bitstream/2027.42/176313/2/alz12823_am.pdf | |
dc.description.bitstreamurl | http://deepblue.lib.umich.edu/bitstream/2027.42/176313/3/alz12823.pdf | |
dc.identifier.doi | 10.1002/alz.12823 | |
dc.identifier.source | Alzheimer’s & Dementia | |
dc.identifier.citedreference | Kuo P-L, Schrack JA, Shardell MD, et�al. A roadmap to build a phenotypic metric of ageing: insights from the Baltimore longitudinal study of aging. J Intern Med. 2020; 287: 373 - 394. | |
dc.identifier.citedreference | Sonnega A, Faul JD, Ofstedal MB, Langa KM, Phillips JW, Weir DR. Cohort profile: the health and retirement study (HRS). Int J Epidemiol. 2014; 43: 576 - 585. | |
dc.identifier.citedreference | Association As. 2021 Alzheimer’s disease facts and figures. Alzheimers Dement. 2021; 17: 327 - 406. | |
dc.identifier.citedreference | Dilworth-Anderson P, Hendrie HC, Manly JJ, Khachaturian AS, Fazio S. Diagnosis and assessment of Alzheimer’s disease in diverse populations. Alzheimers Dement. 2008; 4: 305 - 309. | |
dc.identifier.citedreference | Cooper C, Tandy AR, Balamurali TB, Livingston G. A systematic review and meta-analysis of ethnic differences in use of dementia treatment, care, and research. Am J Geriatr Psychiatry. 2010; 18: 193 - 203. | |
dc.identifier.citedreference | Washington HA. Medical Apartheid: The Dark History of Medical Experimentation on Black Americans from Colonial Times to the Present. Doubleday Books; 2006. | |
dc.identifier.citedreference | Rivera Mindt M, Byrd D, Saez P, Manly J. Increasing culturally competent neuropsychological services for ethnic minority populations: a call to action. Clin Neuropsychol. 2010; 24: 429 - 453. | |
dc.identifier.citedreference | Scharff DP, Mathews KJ, Jackson P, Hoffsuemmer J, Martin E, Edwards D. More than Tuskegee: understanding mistrust about research participation. J Health Care Poor Underserved. 2010; 21: 879 - 897. | |
dc.identifier.citedreference | Shamoo AE. Unethical medical treatment and research in US territories. Account Res. 2022: 1 - 14. | |
dc.identifier.citedreference | NIA. National Institute on Aging: National strategy for recruitment and participation in Alzheimer’s and related dementias Clinical Research. In: https://www.nia.nih.gov/research/recruitment-strategy, editor. 2018. | |
dc.identifier.citedreference | Juster FT, Suzman R. An overview of the health and retirement study. J Hum Resour. 1995: S7 - S56. | |
dc.identifier.citedreference | Burke G, Lima J, Wong ND, Narula J. The multiethnic study of atherosclerosis. Global Heart. 2016; 11: 267 - 268. | |
dc.identifier.citedreference | Bennett DA, Schneider JA, Buchman AS, Barnes LL, Boyle PA, Wilson RS. Overview and findings from the rush memory and aging project. Curr Alzheimer Res. 2012; 9: 646 - 663. | |
dc.identifier.citedreference | Schneiderman N, Llabre M, Cowie CC, et�al. Prevalence of diabetes among Hispanics/Latinos from diverse backgrounds: the Hispanic community health study/study of Latinos (HCHS/SOL). Diabetes care. 2014; 37: 2233 - 2239. | |
dc.identifier.citedreference | Tang M-X, Cross P, Andrews H, et�al. Incidence of AD in African-Americans, Caribbean hispanics, and caucasians in northern Manhattan. Neurology. 2001; 56: 49 - 56. | |
dc.identifier.citedreference | Bienias JL, Beckett LA, Bennett DA, Wilson RS, Evans DA. Design of the Chicago health and aging project (CHAP). J Alzheimers Dis. 2003; 5: 349 - 355. | |
dc.identifier.citedreference | Park VT, Meyer OL, Tsoh JY, et�al. Collaborative Approach for Asian Americans and Pacific Islanders Research and Education (CARE): a recruitment registry for Alzheimer’s disease and related dementias, aging and caregiver-related research. Alzheimers Dement. 2021; 17: e053158. | |
dc.identifier.citedreference | Barnes LL, Shah RC, Aggarwal NT, Bennett DA, Schneider JA. The minority aging research study: ongoing efforts to obtain brain donation in African Americans without dementia. Curr Alzheimer Res. 2012; 9: 734 - 745. | |
dc.identifier.citedreference | Haan MN, Mungas DM, Gonzalez HM, Ortiz TA, Acharya A, Jagust WJ. Prevalence of dementia in older latinos: the influence of type 2 diabetes mellitus, stroke and genetic factors. J Am Geriatr Soc. 2003; 51: 169 - 177. | |
dc.identifier.citedreference | O’Bryant S, Petersen M, Hall J, et�al. Characterizing plasma NfL in a community-dwelling multi-ethnic cohort: results from the HABLE study. Alzheimers Dement. 2022; 18: 240 - 250. | |
dc.identifier.citedreference | Tucker KL, Mattei J, Noel SE, et�al. The Boston Puerto Rican Health Study, a longitudinal cohort study on health disparities in Puerto Rican adults: challenges and opportunities. BMC Public health. 2010; 10: 1 - 12. | |
dc.identifier.citedreference | Sorlie P, Wei GS. Population-based cohort studies: still relevant. J Am Coll Cardiol. 2011; 58: 2010 - 2013. | |
dc.identifier.citedreference | Weiner MW, Nosheny R, Camacho M, et�al. The Brain Health Registry: an internet-based platform for recruitment, assessment, and longitudinal monitoring of participants for neuroscience studies. Alzheimers Dement. 2018; 14: 1063 - 1076. | |
dc.identifier.citedreference | Veitch DP, Weiner MW, Aisen PS, et�al. Using the Alzheimer’s Disease Neuroimaging Initiative to improve early detection, diagnosis, and treatment of Alzheimer’s disease. Alzheimers Dement. 2022; 18: 824 - 857. | |
dc.identifier.citedreference | Majoka MA, Schimming C. Effect of social determinants of health on cognition and risk of Alzheimer disease and related dementias. Clin Ther. 2021; 43: 922 - 929. | |
dc.identifier.citedreference | Camacho MR, Weiner MW, Gonz�lez HM, et�al. Improved methods for recruiting Latino participants for Alzheimer’s disease research using the Brain health Registry. Alzheimer’s Association International Conference. Denver, Colorado: Alzheimer’s and Dementia; 2021; p. e056193. | |
dc.identifier.citedreference | Mueller SG, Weiner MW, Thal LJ, et�al. The Alzheimer’s disease neuroimaging initiative. Neuroimaging Clin N Am. 2005; 15: 869 - 877, xi-xii. | |
dc.identifier.citedreference | Ashford MT, Okonkwo O, Rivera Mindt M, et�al. Efforts to improve recruitment and engagement of underrepresented populations in the Alzheimer’s disease Neuroimaging Initiative (ADNI) study. 14th Conference Clinical Trialson Alzheimer’s Disease. Boston, MA, USA: Journal of the Prevention of Alzheimer’s Disease; 2021. p. LB05. | |
dc.identifier.citedreference | Hill CV, P�rez-Stable EJ, Anderson NA, Bernard MA. The national institute on aging health disparities research framework. Ethn Dis. 2015; 25: 245 - 254. | |
dc.identifier.citedreference | Vick AD, Burris HH. Epigenetics and health disparities. Curr Epidemiol Rep. 2017; 4: 31 - 37. | |
dc.identifier.citedreference | Khachaturian ZS. Emerging Trends in Biomedicine and Health Technology Innovation: Addressing the Global Challenge of Alzheimer’s. OECD Publishing Paris; 2013. | |
dc.identifier.citedreference | Mindt MR, Byrd D, Ryan EL, et�al. Characterization and sociocultural predictors of neuropsychological test performance in HIV+ Hispanic individuals. Cultur Divers Ethnic Minor Psychol. 2008; 14: 315. | |
dc.identifier.citedreference | AsAEAWo NAPA, Khachaturian ZS, Workgroup on NAPA’s scientific agenda for a national initiative on Alzheimer’s disease. Alzheimers Dement. 2012; 8: 357 - 371. | |
dc.identifier.citedreference | Canevelli M, Bruno G, Grande G, et�al. Race reporting and disparities in clinical trials on Alzheimer’s disease: a systematic review. Neurosci Biobehav Rev. 2019; 101: 122 - 128. | |
dc.identifier.citedreference | Birkenbihl C, Salimi Y, Domingo-Fern�nd�z D, et�al. Evaluating the Alzheimer’s disease data landscape. Alzheimers Dement. 2020; 6: e12102. | |
dc.identifier.citedreference | Gleason CE, Zuelsdorff M, Gooding DC, et�al. Alzheimer’s disease biomarkers in Black and non-Hispanic White cohorts: a contextualized review of the evidence. Alzheimers Dement. 2022;18:1545-1564. | |
dc.identifier.citedreference | Gianattasio KZ, Bennett EE, Wei J, et�al. Generalizability of findings from a clinical sample to a community-based sample: a comparison of ADNI and ARIC. Alzheimers Dement. 2021; 17: 1265 - 1276. | |
dc.identifier.citedreference | Gilmore-Bykovskyi AL, Jin Y, Gleason C, et�al. Recruitment and retention of underrepresented populations in Alzheimer’s disease research: a systematic review. Alzheimers Dement. 2019; 5: 751 - 770. | |
dc.identifier.citedreference | Babulal GM, Quiroz YT, Albensi BC, et�al. Perspectives on ethnic and racial disparities in Alzheimer’s disease and related dementias: update and areas of immediate need. Alzheimers Dement. 2019; 15: 292 - 312. | |
dc.identifier.citedreference | Mehta KM, Yeo GW. Systematic review of dementia prevalence and incidence in United States race/ethnic populations. Alzheimers Dement. 2017; 13: 72 - 83. | |
dc.identifier.citedreference | Besser LM, McDonald NC, Song Y, Kukull WA, Rodriguez DA. Neighborhood environment and cognition in older adults: a systematic review. Am J Prev Med. 2017; 53: 241 - 251. | |
dc.identifier.citedreference | Cadar D, Lassale C, Davies H, Llewellyn DJ, Batty GD, Steptoe A. Individual and area-based socioeconomic factors associated with dementia incidence in England: evidence from a 12-year follow-up in the English longitudinal study of ageing. JAMA Psychiatry. 2018; 75: 723 - 732. | |
dc.identifier.citedreference | Karikari TK. Blood tests for Alzheimer’s disease: increasing efforts to expand and diversify research participation is critical for widespread validation and acceptance. J Alzheimers Dis. 2022; Apr 23. Epub ahead of print. | |
dc.identifier.citedreference | Morris JC, Schindler SE, McCue LM, et�al. Assessment of racial disparities in biomarkers for Alzheimer disease. JAMA Neurol. 2019; 76: 264 - 273. | |
dc.identifier.citedreference | Lim U, Wang S, Park SY, et�al. Risk of Alzheimer’s disease and related dementia by sex and race/ethnicity: the multiethnic cohort study. Alzheimers Dement. 2022; 18: 1625 - 1634. | |
dc.identifier.citedreference | Yaffe K, Falvey C, Harris TB, et�al. Effect of socioeconomic disparities on incidence of dementia among biracial older adults: prospective study. BMJ (Clinical research ed). 2013; 347: f7051. | |
dc.identifier.citedreference | Caraballo C, Herrin J, Mahajan S, et�al. Temporal trends in racial and ethnic disparities in multimorbidity prevalence in the United States, 1999-2018. Am J Med. 2022;135:1083-1092. | |
dc.identifier.citedreference | Pathirana TI, Jackson CA. Socioeconomic status and multimorbidity: a systematic review and meta-analysis. Aust N Z J Public Health. 2018; 42: 186 - 194. | |
dc.identifier.citedreference | Ashford MT, Raman R, Miller G, et�al. Screening and enrollment of underrepresented x ethnocultural and educational populations in the Alzheimer’s Disease Neuroimaging Initiative (ADNI). Alzheimers Dement. 2022; Feb 25. Epub ahead of print. | |
dc.identifier.citedreference | Anderson TS, Ayanian JZ, Souza J, Landon BE. Representativeness of participants eligible to be enrolled in clinical trials of aducanumab for Alzheimer disease compared with medicare beneficiaries with Alzheimer disease and mild cognitive impairment. JAMA. 2021; 326: 1627 - 1629. | |
dc.identifier.citedreference | Franzen S, Smith JE, van den Berg E, et�al. Diversity in Alzheimer’s disease drug trials: the importance of eligibility criteria. Alzheimers Dement. 2022; 18: 810 - 823. | |
dc.identifier.citedreference | Babulal GM, Franzen S, Abner EL, et�al. Diversity in Alzheimer’s disease drug trials: reflections on reporting and social construction of race. Alzheimers Dement. 2022; 18: 867 - 868. | |
dc.identifier.citedreference | Ashford M, Kabeto M, Wixom C, et�al. Effects of inclusion/exclusion criteria on ethnocultural and socioeconomic composition of participants in an Alzheimer’s disease clinical trial: analysis of Health and Retirement Study (HRS) data. Clinical trials in Alzheimer’s disease 2021: The general of prevention of Alzheimer’s disease. 2021: S73 - S170. | |
dc.working.doi | NO | en |
dc.owningcollname | Interdisciplinary and Peer-Reviewed |
Files in this item
Remediation of Harmful Language
The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.
Accessibility
If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.